Triveni Bio
Focus: Triveni Bio is a genetics-informed precision medicine biotech founded in 1993, headquartered in Watertown, MA, focused on oncology and rare diseases. As a public company, it operates at mid-cap scale with a focused pipeline in specialty therapeutics.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
2-2 this month
Stable — net -2 jobs in 30d
2 added, 4 removed. Backfill posture.
Should You Work at Triveni Bio?
AI assessmentBest suited for specialists seeking precision medicine expertise with stable financials, but limited by thin pipeline and modest hiring velocity.
Why Work Here
- Perfect-record H1B sponsorship (9 approvals, 0 denials in 2023) signals strong international talent recruitment
- Genetics-informed precision medicine focus offers cutting-edge career development in an emerging therapeutic paradigm
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
TRIV-509
Atopic DermatitisClinical Trials (1)
NCT07167758A Study Evaluating TRIV-509 in Atopic Dermatitis
Phase 2Help build intelligence for Triveni Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.